Pharma Stock Soars 4 per cent Following FDA Approval and Strategic Partnership with Leading US Company Pharma Stock Soars 4 per cent Following FDA Approval and Strategic Partnership with Leading US Company FDA Nod for Key Diabetes Treatment Boosts Market Confidence and Stock Performance DSIJ Intelligence / Tuesday, January 7, 2025 / Article rating: 5.0 FDA Nod for Key Diabetes Treatment Boosts Market Confidence and Stock Performance
Pharma Stock Jumps 4.5 per cent After Japan’s Nod for Injectable Biosimilar Pharma Stock Jumps 4.5 per cent After Japan’s Nod for Injectable Biosimilar A key injectable biosimilar gets the green light from Japan, driving a 4.5 per cent surge in stock price. DSIJ Intelligence / Tuesday, January 7, 2025 / Article rating: 5.0 A key injectable biosimilar gets the green light from Japan, driving a 4.5 per cent surge in stock price.